Objectives: To explore the cause of third-generation cephalosporin resistance in Australian Acinetobacter baumannii isolates belonging to global clone 1 (GC1).
Introduction
In Acinetobacter baumannii, resistance to third-generation cephalosporins such as ceftazidime and cefotaxime can arise as a consequence of increased expression of the chromosomal ampC gene. When the insertion sequence (IS) ISAba1 is present in the appropriate orientation upstream of ampC, an outwardfacing promoter in ISAba1 directs transcription of ampC, increasing its expression. 1 -3 This mechanism appears to be widespread and ISAba1 is generally found upstream of the ampC gene in isolates that are resistant to third-generation cephalosporins. 4 -8 Another IS, ISAba125, has also been detected upstream of ampC and it also increases ampC expression leading to cephalosporin resistance. 9 A surprising finding was that an identical ISAba125-ampC segment was found in both ACICU a global clone 2 (GC2) isolate and a global clone 1 (GC1) isolate from Greece, and that this resulted from the transfer of a 10 kb chromosomal DNA segment from the GC1 lineage to the GC2 lineage. 9 Mobilization of an ampC gene, believed to have originated in A. baumannii, into Oligella urethralis has also been reported. 10 However, to date, mobilization of an Acinetobacter ampC gene via a transposon has not been reported.
We previously examined a small collection of GC1 A. baumannii isolates from Australian hospitals and showed that the presence of ISAba1 upstream of ampC correlated with cephalosporin resistance. 7 Here, we have measured the MIC and the level of ampC expression in these isolates. In isolates carrying an ISAba1-ampC configuration, we examined whether the ampC gene was in the normal location in the chromosome. This led to the identification of a transposon carrying an A. baumannii ampC gene.
Methods

Bacterial isolates
The strains used are listed in Table 1 . Most have been described previously. 7,11 -13 Melissa Brown (Flinders University, Adelaide, Australia) supplied strain 6772166 14 from Royal Adelaide Hospital. G7 and RBH3 (previously referred to as F3) 7 were detected among representatives of collections reported previously 15, 16 and supplied by Anton Peleg (Monash University, 
Strain characterization
Isolates were all screened for resistance to ceftazidime and cefotaxime using disc diffusion and MICs determined using microbroth dilution. 20 Multilocus sequence typing (MLST) was performed using the Oxford scheme, modified as described previously. 7 
DNA procedures
DNA was isolated and short-and long-range PCR conducted as described previously. 7 Primers and their locations are listed in Table S1 (available as Supplementary data at JAC Online). PCR amplicons were digested with restriction enzymes to confirm their identity. Amplicons were purified, sequenced and sequences analysed as described previously. 7 
Quantitative real-time PCR
The level of ampC gene transcripts relative to 16S rRNA was measured using quantitative real-time PCR (qRT-PCR). Total RNA was isolated using the Isolate RNA Mini Kit (Bioline, Australia) and its integrity checked by electrophoresis. RNA samples were treated with Amplification Grade DNase I (Sigma-Aldrich, St Louis, MO, USA) to remove contaminating genomic DNA. Then, cDNA was synthesized using the SuperScript w VILO TM cDNA Synthesis Kit (Invitrogen, Carlsbad, CA, USA). cDNA levels were quantified on an ABI7500 Real-Time PCR System using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) and primers designed for ampC and 16S rRNA, described previously. 9 PCR was for 40 cycles with an annealing temperature of 608C. Triplicate determinations were averaged.
GenBank accession numbers
The DNA sequences of Tn6168 and surrounds and of the folE-ampC region from strain A85 have been submitted to GenBank under accession number KC118540. The sequence of the chromosomal ampC allele of isolate J9 has been submitted to GenBank under accession number KF002790.
Results and discussion
Cephalosporin-resistant isolates carry ISAba1 upstream of ampC
The MIC of ceftazidime and cefotaxime determined for GC1 isolates recovered over the period 1997-2010 (Table 1 ) correlated well with predictions from the annular radius around discs containing 30 mg of ceftazidime or 30 mg of cefotaxime, if a radius ≥4 mm (corresponds to a 14 mm diameter) was interpreted as susceptible. The early GC1 isolate A1 from the UK 19 was susceptible and AB0057 18 was resistant. ISAba1 was detected upstream of an ampC gene in all ceftazidime-and cefotaxime-resistant isolates, butnot in anyof the 
Location of ampC genes associated with ISAba1
For all susceptible isolates, a PCR designed to detect any IS upstream of the ampC gene in its normal location in the chromosome adjacent to the folE gene 9 (Figure 1a ) yielded the 1667 bp amplicon predicted when no IS is present. A larger fragment of 2853 bp was amplified from most of the ceftazidime-and cefotaxime-resistant isolates, consistent with the presence of ISAba1 between the folE and ampC genes. However, three sporadic ceftazidime-resistant isolates (RBH3, A85 and 6772166), recovered in different cities over the period 2002-03, had ISAba1 upstream of ampC but yielded an amplicon of the size expected if there is no IS between folE and ampC. The sequence of this amplicon from each of the three isolates was identical to that found in other GC1 isolates (3208 and D2) reported previously 9 or determined here for A83. It was concluded that the ISAba1-ampC amplicon detected in RBH3, A85 and 6772166 derives from a second ampC gene. The sequence of this amplicon was the same for all three isolates. The sequence was also identical to that of a region in the genome of the GC1 isolate AB0057 (GenBank accession number CP001182).
Tn6168, a composite transposon carrying the ampC gene
The chromosome of GC1 isolate AB0057 was known to contain two copies of ampC, one in the normal location that is not preceded by an IS and a second copy adjacent to an ISAba1 and located near the origin of replication. 18 We examined this region more closely and found that the additional ampC is part of a 3155 bp continuous segment that is derived from an A. baumannii chromosome and is flanked by directly oriented copies of ISAba1 (Figure 1b) . This structure is flanked by a 9 bp direct duplication, as expected for ISAba1.
It is between open reading frames AB57_0006 and AB57_0013 (in CP001182), which both predict products that are resistancenodulation -division efflux pumps, and these genes are adjacent in other available GC1 genomes. Hence, the structure is a composite transposon that was named Tn6168.
A85, RBH3 and 6772166 were screened for the presence of Tn6168 using primers listed in Table S1 . AB0057 was the control. In all three, Tn6168 was present and the sequence of the amplicon linking ampC to the flanking sequence (RH741 to RH582) was identical, indicating that the transposon in A85, RBH3 and 6772166 is in the same location as it is in AB0057. The complete sequence of the transposon and surrounds from A85 was determined and was identical to that found in AB0057, except for an additional base in the right-hand ISAba1 of AB0057. A further GC1 isolate carrying Tn6168 in the same position was detected via searches of the GenBank whole genome sequence database (last searched 27 June 2013). The sequence type (ST) of isolate Canada BC-5 (GenBank accession number AFDN01000002) was found to be ST1 (Institut Pasteur MLST scheme) and hence this isolate is also a GC1 member.
Origin of Tn6168
The sequences of the central portion of Tn6168 and the resident chromosomal copy in GC1 strains differ at 72 positions. In Tn6168, 15 bases of the ampC gene (bp 729-743) were duplicated, causing a duplication of the last five amino acids of the V loop. Sixty-eight differences were single base substitutions, including 22 that were in ampC causing five amino acid substitutions and 20 that were in the adjacent open reading frame (orf in Figure 1b) . The amino acid differences in AmpC did not affect any of the critical residues identified in previous studies. 4 The remaining base substitutions and three 1 -3 bp additions/deletions were in the 65/68 bp between the termination codons of ampC and the orf. A potential bidirectional r-independent terminator was found in this location and the stem-loop structure was not disrupted by the substitutions located within it.
A possible origin for this segment was found in several draft genomes, which had sequences differing by 1 -2 bp from that in Tn6168 and lacking the 15 bp duplication (Table S2 , available as Supplementary data at JAC Online). The ST of the isolates listed in Table S1 was determined from the genome data. Those without an ISAba1 upstream of ampC were identified as ST32 (Institut Pasteur scheme) or ST463/ST472 (Oxford MLST scheme). The remaining genomes were from ST3 (Institut Pasteur MLST scheme) isolates (corresponding to European clone III) and these carried an ISAba1 9 bp from the ATG of ampC, whereas, in Tn6168, ISAba1 is only 7 bp from the ATG codon.
Transposon Tn6168 in other A. baumannii isolates
Only a few ceftazidime-and cefotaxime-resistant isolates were found among the collection of .400 Australian Acinetobacter isolates, both sporadic and outbreak, we have screened to date. This collection included 89 isolates that are not GC1 or GC2 and 65 of these did not include a detectable oxa-Ab gene, indicating that they are probably not A. baumannii. Two cephalosporin-resistant isolates that were not GC1 or GC2 but included ISAba1 upstream Tn6168 carrying an ISAba1-activated ampC gene in A. baumannii
